Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ebola virus-like particles prevent lethal Ebola virus infection

10.12.2003


Scientists have successfully immunized mice against Ebola virus using hollow virus-like particles, or VLPs, which are non-infectious but capable of provoking a robust immune response. These Ebola VLPs conferred complete protection to mice exposed to lethal doses of the virus.



The work could serve as a basis for development of vaccines and other countermeasures to Ebola, which causes hemorrhagic fever with case fatality rates as high as 80 percent in humans. The virus, which is infectious by aerosol, is of concern both as a global health threat and a potential agent of biological warfare or terrorism. Currently there are no available vaccines or therapies.

In a study published in this week’s online edition of Proceedings of the National Academy of Sciences, Sina Bavari and colleagues at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) describe creating VLPs from two Ebola virus proteins, glycoprotein (GP) and matrix protein (VP40). These VLPs resemble a shell of infectious viral particles but lack the genetic material necessary for reproduction.


When the VLPs were injected into mice, they activated both arms of the immune response. Specifically, they induced cell-mediated immunity via T cells and humoral immunity via B cells. Both are necessary for complete protection against the Ebola virus.

Having shown that the VLPs evoked a robust immune response, the team next examined whether this response could protect mice from lethal challenge with Ebola virus. Mice were vaccinated with VLPs three times at three-week intervals and challenged with the virus six weeks after the last vaccination. The result was 100 percent protection with no signs of illness in the immunized mice.

"This is astonishing work," said Colonel Erik A. Henchal, commander of USAMRIID. "The ability to produce self-assembling particles that resemble whole virus will give us a new tool to evaluate the combination of variables required to produce a protective immune response to Ebola virus."

According to Bavari, VLPs have already been tested and found efficacious as vaccines for several other viruses, including papillomavirus, HIV, parvovirus, and rotavirus. His team hopes to build upon its work by evaluating the efficacy of VLPs for both Ebola and Marburg, a related virus, in nonhuman primates.

"The beauty of this approach is that VLPs are not a traditional vaccine platform, so you don’t have to worry about the recipient building up an immunity to that platform," Bavari explained. "It looks like a virus, so you have the protective immune response, but it’s basically an empty shell."

VLPS also have potential application beyond vaccine development--for example, they could be used to develop diagnostic reagents for identifying Ebola-infected samples. In addition, generating VLPs containing additional structural proteins will be useful in determining the mechanisms of the immune responses to Ebola virus infection.

Study collaborators were Kelly L. Warfield, Catharine M. Bosio, Brent C. Welcher, Emily M. Deal, Alan Schmaljohn, and M. Javad Aman, all of USAMRIID, and Mansour Mohamadzadeh of the Department of Medicine at Tulane University.


USAMRIID, located at Fort Detrick, Maryland, is the lead laboratory for the Medical Biological Defense Research Program, and plays a key role in national defense and in infectious disease research. The Institute’s mission is to conduct basic and applied research on biological threats resulting in medical solutions (such as vaccines, drugs and diagnostics) to protect the warfighter. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Materiel Command.

Caree Vander Linden | EurekAlert!
Further information:
http://www.usamriid.army.mil/

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>